Advisor Groups’ shares along with several other investors

According to the company in its latest reveal of filing with the SEC, the position of the logoAlps Advisors Inc has been raised in the shares of the renowned Supernus Pharmaceuticals Inc. by 6.8 percent in the 1st quarter. There was the possession of 10,532 shares by the fund of the stock of the Pharmaceuticals’ firm after getting the acquisition of an extra 666 shares during the period. The holdings of the Alps Advisors Inc. in the stock of Supernus Pharmaceuticals Inc. were valued at amount $369K at the time of its recent filing with the Securities & Exchange Commission.

Various other institutional investors also either decreased or added to their holdings in the specialty pharma company. Asset Management Inc. raised its position in the stock of Supernus Pharmaceuticals Inc. by 511.1 percent in the 4th quarter. Now the investor has the possession of 880 shares of the stock of specialty Pharma Company which are valued at $30K after getting the acquisition of an extra 736 shares in the latest quarter. Another investor, Financial Gravity Wealth Inc. got the acquisition of a raised position in the shares of the specialty Pharma Company during the 1st quarter which is valued at $44K. Advisor Group Inc. also raised its holdings in the shares of the specialty Pharma Company by 17.2 percent. At present, the Advisor Group Inc. has the possession of 2,082 shares of the Supernus Pharmaceuticals Inc.’s shares which are valued at $69K after getting the acquisition of an extra 306 shares during the quarter.

Cutler Group LP raised its holdings in the shares of the stock of specialty Pharma Company in the 4th quarter which can be valued at $89K. Lastly, Huntington National Bank increased its holdings in the shares of the Pharma Company by 881.4 percent during the 1st quarter. At present, the Huntington National Bank has possession of 4,485 shares of the Pharma Company.